iodine has been researched along with Depression, Endogenous in 9 studies
Iodine: A nonmetallic element of the halogen group that is represented by the atomic symbol I, atomic number 53, and atomic weight of 126.90. It is a nutritionally essential element, especially important in thyroid hormone synthesis. In solution, it has anti-infective properties and is used topically.
diiodine : Molecule comprising two covalently bonded iodine atoms with overall zero charge..
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (55.56) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nau, JY | 1 |
| KEITEL, HG | 1 |
| SHERER, MG | 1 |
| KANAYA, R | 1 |
| OPPENHEIMER, JH | 1 |
| FISHER, LV | 1 |
| NELSON, KM | 1 |
| JAILER, JW | 1 |
| GRUENNER, O | 1 |
| Hermann, D | 1 |
| Hewer, W | 1 |
| Lederbogen, F | 1 |
| Brown, L | 1 |
| Bryant, C | 1 |
| Brown, VM | 1 |
| Bei, B | 1 |
| Judd, FK | 1 |
| Modi, AC | 1 |
| Quittner, AL | 1 |
| Skutsch, GM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase II Study: LYM-X-SORB™, an Organized Lipid Matrix: Fatty Acids and Choline in CF[NCT00406536] | Phase 2 | 110 participants (Actual) | Interventional | 2007-01-31 | Completed | ||
| Sustained Impact of Hypertonic Saline on Mucociliary Clearance in Young Children With Cystic Fibrosis[NCT01031706] | 23 participants (Actual) | Interventional | 2009-09-30 | Completed | |||
| Pragmatic Implementation Trial of a CF Primary Palliative Care Intervention[NCT04923880] | 643 participants (Actual) | Interventional | 2021-06-25 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
"Average radio tracer clearance through 90 minutes (MCC90) is primary index of mucociliary clearance at each study.~Primary study outcome: is absolute change in MCC90 between baseline and at end of treatment (where MCC measured 8-12 hours after final dose of study drug) - reflects sustained impact on MCC" (NCT01031706)
Timeframe: Baseline versus after completion of 4 week treatment period
| Intervention | percent clearance (Mean) |
|---|---|
| Hypertonic Saline | 2.77 |
| Placebo | -2.35 |
Absolute change in % predicted FEV1 between baseline and after 4 weeks of treatment calculated (NCT01031706)
Timeframe: Baseline and after 4 weeks of treatment
| Intervention | Percentage of predicted FEV1 (Mean) |
|---|---|
| Hypertonic Saline | 3.38 |
| Placebo | 1.09 |
9 other studies available for iodine and Depression, Endogenous
| Article | Year |
|---|---|
[Not Available].
Topics: Abnormalities, Drug-Induced; Alcoholism; Antidepressive Agents; Autistic Disorder; Cardiovascular Di | 2016 |
Marked depression of the plasma protein-bound iodine concentration in the absence of clinical hypothyroidism during testosterone medication.
Topics: Blood Proteins; Depressive Disorder; Humans; Hypothyroidism; Iodine; Testosterone | 1957 |
Depression of iodide uptake of the thyroid by thiocyanate through blocking of the energy supply.
Topics: Depression; Depressive Disorder; Humans; Iodides; Iodine; Thiocyanates; Thyroid Gland | 1959 |
Depression of the serum protein-bound iodine level by diphenylhydantion.
Topics: Blood Proteins; Brain; Brain Diseases; Depression; Depressive Disorder; Humans; Hydantoins; Iodine; | 1961 |
SPA THERAPY IN NEUROSES.
Topics: Anxiety; Anxiety Disorders; Arteriosclerosis; Balneology; Carbon Dioxide; Depression; Depressive Dis | 1964 |
Testing the association between thyroid dysfunction and psychiatric diagnostic group in an iodine-deficient area.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Causality; Depressive Disorder; Female; Germany; Goiter, | 2004 |
Self-compassion weakens the association between hot flushes and night sweats and daily life functioning and depression.
Topics: Activities of Daily Living; Adaptation, Psychological; Affect; Cross-Sectional Studies; Depression; | 2014 |
Validation of a disease-specific measure of health-related quality of life for children with cystic fibrosis.
Topics: Adolescent; Child; Cystic Fibrosis; Depressive Disorder; Female; Humans; Male; Predictive Value of T | 2003 |
Validation of a disease-specific measure of health-related quality of life for children with cystic fibrosis.
Topics: Adolescent; Child; Cystic Fibrosis; Depressive Disorder; Female; Humans; Male; Predictive Value of T | 2003 |
Validation of a disease-specific measure of health-related quality of life for children with cystic fibrosis.
Topics: Adolescent; Child; Cystic Fibrosis; Depressive Disorder; Female; Humans; Male; Predictive Value of T | 2003 |
Validation of a disease-specific measure of health-related quality of life for children with cystic fibrosis.
Topics: Adolescent; Child; Cystic Fibrosis; Depressive Disorder; Female; Humans; Male; Predictive Value of T | 2003 |
Validation of a disease-specific measure of health-related quality of life for children with cystic fibrosis.
Topics: Adolescent; Child; Cystic Fibrosis; Depressive Disorder; Female; Humans; Male; Predictive Value of T | 2003 |
Validation of a disease-specific measure of health-related quality of life for children with cystic fibrosis.
Topics: Adolescent; Child; Cystic Fibrosis; Depressive Disorder; Female; Humans; Male; Predictive Value of T | 2003 |
Validation of a disease-specific measure of health-related quality of life for children with cystic fibrosis.
Topics: Adolescent; Child; Cystic Fibrosis; Depressive Disorder; Female; Humans; Male; Predictive Value of T | 2003 |
Validation of a disease-specific measure of health-related quality of life for children with cystic fibrosis.
Topics: Adolescent; Child; Cystic Fibrosis; Depressive Disorder; Female; Humans; Male; Predictive Value of T | 2003 |
Validation of a disease-specific measure of health-related quality of life for children with cystic fibrosis.
Topics: Adolescent; Child; Cystic Fibrosis; Depressive Disorder; Female; Humans; Male; Predictive Value of T | 2003 |
Manic depression--a disorder of central dopaminergic rhythm.
Topics: Acetylcholine; Aldosterone; Bipolar Disorder; Circadian Rhythm; Climate; Depressive Disorder; Dopami | 1981 |